AVGO(AVGO)
AVGO
Q3 2026 EPS Estimate
$3.22
Sep 3, 2026 · Reports after close
Revenue Estimate
$29.22B
FY2026E EPS$11.57
FY2027E EPS$19.43
Analyst Sentiment
Wall St. Consensus
Buy26 analysts·High coverage
72
Score
23 Buy (88%)3 Hold (12%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
2388%
Hold
312%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$400.00
+9.6%
Consensus
$508.50
+39.3%
Bull
$582.00
+59.4%
12-Month Target Range26 analysts
$400.00$508.50$582.00
Current $365.02Consensus
Current Price
$365.02
Upside to Consensus
$143.48
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+64.81%
EPS+67.91%
FY2028
Rev+33.30%
EPS+33.54%
FY2029
Rev+18.68%
EPS-14.18%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $105.41B | $173.73B | $231.57B | $274.82B | $139.00B |
| Low | $86.78B | $118.90B | $229.77B | $209.62B | $106.03B |
| High | $109.45B | $191.63B | $233.37B | $300.93B | $152.21B |
| EBITDA Avg | $56.76B | $93.54B | $124.69B | $147.98B | $74.85B |
| Low | $46.73B | $64.02B | $123.72B | $112.87B | $57.09B |
| High | $58.94B | $103.18B | $125.66B | $162.04B | $81.96B |
| EBIT Avg | $39.71B | $65.45B | $87.24B | $103.53B | $52.36B |
| Low | $32.69B | $44.79B | $86.56B | $78.97B | $39.94B |
| High | $41.23B | $72.19B | $87.92B | $113.37B | $57.34B |
| Net Income Avg | $60.18B | $94.96B | $107.89B | $108.07B | $169.86B |
| Low | $53.77B | $79.87B | $89.73B | $74.74B | $117.47B |
| High | $66.60B | $110.06B | $148.49B | $121.42B | $190.84B |
| EPS Avg | $11.57 | $19.43 | $25.95 | $22.27 | $35.00 |
| Low | $11.08 | $16.46 | $18.49 | $15.40 | $24.21 |
| High | $13.72 | $22.68 | $30.60 | $25.02 | $39.32 |
| Analysts (Rev / EPS) | 31 / 27 | 36 / 27 | 27 / 13 | 13 / 5 | 18 / 5 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $29.22B | $34.42B | $36.58B | $40.44B | $44.65B | $50.21B | $54.53B | $55.82B |
| Low | $29.16B | $24.67B | $33.31B | $36.83B | $40.67B | $45.73B | $49.67B | $50.84B |
| High | $29.45B | $37.61B | $38.21B | $42.25B | $46.64B | $52.45B | $56.97B | $58.31B |
| EBITDA Avg | $15.73B | $18.53B | $19.69B | $21.78B | $24.04B | $27.04B | $29.36B | $30.06B |
| Low | $15.70B | $13.28B | $17.94B | $19.83B | $21.90B | $24.62B | $26.74B | $27.37B |
| High | $15.86B | $20.25B | $20.57B | $22.75B | $25.11B | $28.24B | $30.67B | $31.40B |
| EBIT Avg | $11.01B | $12.97B | $13.78B | $15.24B | $16.82B | $18.92B | $20.54B | $21.03B |
| Low | $10.99B | $9.29B | $12.55B | $13.88B | $15.32B | $17.23B | $18.71B | $19.15B |
| High | $11.09B | $14.17B | $14.39B | $15.92B | $17.57B | $19.76B | $21.46B | $21.97B |
| Net Income Avg | $15.67B | $18.71B | $19.92B | $21.93B | $24.53B | $27.78B | $29.76B | $29.99B |
| Low | $14.99B | $17.54B | $17.61B | $19.39B | $21.68B | $24.56B | $26.30B | $26.51B |
| High | $15.96B | $20.07B | $21.07B | $23.20B | $25.95B | $29.39B | $31.48B | $31.73B |
| EPS Avg | $3.21 | $3.84 | $4.08 | $4.50 | $5.03 | $5.70 | $6.10 | $6.15 |
| Low | $3.07 | $3.60 | $3.61 | $3.98 | $4.45 | $5.04 | $5.39 | $5.44 |
| High | $3.27 | $4.12 | $4.32 | $4.76 | $5.32 | $6.03 | $6.46 | $6.51 |
| Analysts (Rev / EPS) | 22 / 24 | 22 / 22 | 19 / 18 | 11 / 10 | 11 / 10 | 17 / 16 | 10 / 11 | 10 / 11 |